EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

30.30p
   
  • Change Today:
    -0.70p
  • 52 Week High: 31.30p
  • 52 Week Low: 18.75p
  • Currency: UK Pounds
  • Shares Issued: 449.09m
  • Volume: 304,838
  • Market Cap: £136.08m
  • Beta: 0.01

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 30.30p
Change Today -0.70p
% Change -2.26 %
52 Week High 31.30p
52 Week Low 18.75p
Volume 304,838
Shares Issued 449.09m
Market Cap £136.08m
Beta 0.01

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.81% below the market average91.81% below the market average91.81% below the market average91.81% below the market average91.81% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average
Price Trend
79.68% above the market average79.68% above the market average79.68% above the market average79.68% above the market average79.68% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average
Income Not Available
Growth
60.47% above the market average60.47% above the market average60.47% above the market average60.47% above the market average60.47% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 04-Aug-2025

Time Volume / Share Price
13:11 200,000 @ 30.70p
16:08 3,490 @ 30.30p
16:07 3,490 @ 30.30p
15:32 3 @ 30.80p
14:56 17,937 @ 29.97p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page